James G. Wolf - Oct 28, 2022 Form 3/A - Amendment Insider Report for ENZO BIOCHEM INC (ENZ)

Role
10%+ Owner
Signature
James G. Wolf
Stock symbol
ENZ
Transactions as of
Oct 28, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
1/12/2023, 08:54 PM
Date Of Original Report
Jan 9, 2023
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENZ Common Stock, $0.01 par value 3.56M Oct 28, 2022 Direct
holding ENZ Common Stock, $0.01 par value 116K Oct 28, 2022 See Footnote F1
holding ENZ Common Stock, $0.01 par value 22K Oct 28, 2022 See Footnote F2
holding ENZ Common Stock, $0.01 par value 110K Oct 28, 2022 See Footnote F3
holding ENZ Common Stock, $0.01 par value 171K Oct 28, 2022 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENZ Long Call Option (right to buy) Oct 28, 2022 Common Stock 275K $2.50 Direct F5
holding ENZ Long Call Option (right to buy) Oct 28, 2022 Common Stock 200K $5.00 Direct F5
holding ENZ Long Call Option (right to buy) Oct 28, 2022 Common Stock 75K $2.50 Direct F5
holding ENZ Long Call Option (right to buy) Oct 28, 2022 Common Stock 80.7K $5.00 Direct F5
holding ENZ Long Call Option (right to buy) Oct 28, 2022 Common Stock 75K $7.50 Direct F5
holding ENZ Short Put Option (obligation to buy) Oct 28, 2022 Common Stock 400K $2.50 Direct F6
holding ENZ Short Put Option (obligation to buy) Oct 28, 2022 Common Stock 34.5K $5.00 Direct F6
holding ENZ Short Put Option (obligation to buy) Oct 28, 2022 Common Stock 30K $2.50 Direct F6
holding ENZ Short Put Option (obligation to buy) Oct 28, 2022 Common Stock 23.9K $2.50 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person.
F2 These shares are held in a qualified retirement account in the name, and for the benefit, of the Reporting Person's spouse. The Reporting Person has dispositive and voting control over the retirement account. The Reporting Person disclaims beneficial ownership of the securities held by this retirement account, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F3 These shares are held directly by the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F4 These shares are held directly by the Reporting Person's adult children, each holding a portion of the shares individually. The Reporting Person maintains powers of attorney granted by each of his adult children with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his adult children. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F5 Each call option may be exercised from the date it was purchased through the expiration date of the call option.
F6 Each put option may be exercised by the owner of the option at any time from the date of its sale through the expiration date of the put option.
F7 This amendment to Form 3 is being filed to correct the original Form 3 filed on January 9, 2023. The original Form 3 inadvertently omitted certain short put options with an exercise price of $2.50 that expired on November 18, 2022.